+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunomodulators Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 179 Pages
  • August 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5417332
Immunomodulators are medications that either stimulate or inhibit the immune system. They affect the immunological response by modifying the immune system. Immunomodulators function by lowering the amount of antibodies produced in response to foreign antigens, which stimulate immune reactions. Immunosuppressants and immunostimulants are two different categories of immunomodulators. Corticosteroids, thymosin, and immunoglobulins are a few of the Immunomodulators. Cancer, infection, asthma, and other disorders are treated with these drugs. Immunosuppressants are commonly used to avoid organ rejection during various transplant procedures. Immunostimulants could possibly be utilized to treat HIV and cancer.



Inflammatory bowel disease (IBD), notably ulcerative colitis (UC), and Crohn's disease (CD), can be effectively treated with immunomodulators. Immunomodulators are also commonly employed in organ transplants and the treatment of autoimmune illnesses. Steroids are sometimes taken in conjunction with immunomodulators to speed up the effect of immunomodulators. They are used in contemporary vaccination formulations and play an important role in pharmaceuticals. Immunomodulation focuses on manipulating the immune system to reduce infections and other negative health impacts while maintaining precise control to avoid problems such as frequent and recurrent pneumonia, bronchitis, sinus infections, ear infections, meningitis or skin infections, and others. Simultaneously, efforts to improve animal and human health by suppressive or potentiating measures are made.

Market Dynamics


The rising prevalence of autoimmune illnesses such as rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, Psoriatic arthritis, and others is a major contributor to the global immunomodulators market's expansion. For instance, according to the National Institutes of Health, up to 23.5 million Americans (almost 7% of the population) had an autoimmune disease in 2017, resulting in a larger patient pool and, in turn, a larger market.

Key features of the study:

  • This report provides in-depth analysis of the immunomodulators market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global Immunomodulators market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Biogen Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Amgen, Inc., Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global immunomodulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the immunomodulators market

Detailed Segmentation:


Global Immunomodulators Market, By Product Type:

  • Immunosuppressants
  • Calcineurin Inhibitors
  • Glucocorticoids
  • Antimetabolites
  • Others
  • Immunostimulants
  • Vaccines
  • Antibodies
  • Others

Global Immunomodulators Market, By Application:

  • Oncology
  • Respiratory
  • HIV
  • Others

Global Immunomodulators Market, By End User:

  • Hospitals
  • Clinics
  • Others

Global Immunomodulators Market, By Region:

  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • Abbott Laboratories
  • Johnson & Johnson
  • Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Frequently Asked Questions about the Immunomodulators Market

What is the estimated value of the Immunomodulators Market?

The Immunomodulators Market was estimated to be valued at $91850 Million in 2021.

What is the growth rate of the Immunomodulators Market?

The growth rate of the Immunomodulators Market is 7.9%, with an estimated value of $156378.2 Million by 2028.

What is the forecasted size of the Immunomodulators Market?

The Immunomodulators Market is estimated to be worth $156378.2 Million by 2028.

Who are the key companies in the Immunomodulators Market?

Key companies in the Immunomodulators Market include F. Hoffmann, La Roche Ltd., Biogen Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Amgen, Inc., Bristol, Myers Squibb Company and Eli Lilly and Company.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Immunomodulators Market Insights
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Market Trends
  • New Product Launches
  • Key Developments
  • Regulatory Scenario
  • Advances in R&D for Immunology
  • Collaborations & Acquisitions
  • Epidemiology
  • PEST Analysis
  • Porter’s five forces analysis

4. Global Immunomodulators Market- COVID-19 Impact Analysis
  • Economic Impact
  • COVID-19 Epidemiology
  • Impact of COVID-19 on demand and supply chain

5. Global Immunomodulators Market, By Product Type, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Immunosuppressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Calcineurin Inhibitors
  • Glucocorticoids
  • Antimetabolites
  • Others
  • Immunostimulants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Vaccines
  • Antibodies
  • Others

6. Global Immunomodulators Market, By Application, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • HIV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Immunomodulators Market, By End User, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

8. Global Immunomodulators Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Region at Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2028, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Snapshot
Company Profiles
  • F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Biogen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amgen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bristol-Myers Squibb Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Merck Sharp & Dohme Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd.
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • Abbott Laboratories
  • Johnson & Johnson
  • Pfizer Inc.